Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Practice Tip: Prepare Yourself and Your Employee Witness for the 'Regulatory' Deposition

By Julie Blum
May 26, 2005

During the course of discovery in product liability matters, a key liability theme is often whether the defendant company complied with its regulatory obligations in connection with the product at issue. For example, in product liability litigation concerning chemical compounds, the focus might be on whether the company properly registered the compound with the EPA or with state environmental agencies. Likewise, in a pharmaceutical or medical device product liability case, plaintiffs will often focus on whether the product complied with FDA regulatory requirements. Plaintiffs' approach to such liability issues will often result in depositions that focus on whether, how, and when the defendant company informed the appropriate regulatory agencies of any risks potentially associated with use of the product at issue. Did the company submit the requisite scientific data; did it properly report known adverse events associated with the product at issue, and did it seek appropriate approval from the regulatory agency regarding the nature of its warnings to users and consumers? To that end, plaintiffs will often notice depositions of fact witnesses whom they think can provide testimony on the company's regulatory compliance or they may seek depositions pursuant to Fed. R. Civ. P. 30(B)(6) of witnesses “with knowledge” of the company's regulatory compliance.

A very basic, yet critical, component of the successful defense of a product in product liability litigation is the thorough preparation of the defendant company's employee witnesses who may be called to testify about regulatory compliance. Although such witnesses may be well versed in the regulations that govern the product at issue, they often walk into depositions woefully unprepared to deal with deposition “tactics.” So how can one thoroughly prepare a company witness who will be asked to testify regarding the company's compliance with governing regulatory schemes? First, learn the regulations yourself well in advance of your meeting with the witness. Become familiar with the regulatory scheme that governs the registration and marketing or sales of your client's product. Obtain and read all documents that reflect contacts between your client and the regulatory authority. Second, have the witness walk you very carefully through his/her understanding of the regulations and the company's compliance with them. This is important so that you can assess the witness's knowledge, as well as to further your own education about the company's regulatory compliance. Review the regulatory documents with the witness. Know which documents he has specific knowledge of and which ones he does not. Third, make sure that the witness is familiar with the deposition process itself and understands the mechanics of the deposition, eg, what to do when you object, not to speculate when giving answers, etc. Fourth, and perhaps most important, prepare your witness well for the “trap” questions. These are questions that assume regulatory requirements, which often are not imposed in the manner suggested by the question. Consider the following deposition question typical of one posed by plaintiffs in a pharmaceutical product liability case:

This premium content is locked for Entertainment Law & Finance subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

How AI Has Affected PR Image

When we consider how the use of AI affects legal PR and communications, we have to look at it as an industrywide global phenomenon. A recent online conference provided an overview of the latest AI trends in public relations, and specifically, the impact of AI on communications. Here are some of the key points and takeaways from several of the speakers, who provided current best practices, tips, concerns and case studies.

CLE Shouldn't Be the Only Mandatory Training for Attorneys Image

Each stage of an attorney's career offers opportunities for a curriculum that addresses both the individual's and the firm's need to drive success.